<SEC-DOCUMENT>0001193125-20-210700.txt : 20200805
<SEC-HEADER>0001193125-20-210700.hdr.sgml : 20200805
<ACCEPTANCE-DATETIME>20200805163830
ACCESSION NUMBER:		0001193125-20-210700
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20200805
DATE AS OF CHANGE:		20200805
EFFECTIVENESS DATE:		20200805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-241003
		FILM NUMBER:		201078182

	BUSINESS ADDRESS:	
		STREET 1:		5 BAZEL ST
		STREET 2:		P O B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
		BUSINESS PHONE:		9729267267

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		5 BAZEL ST PO B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d50479ds8.htm
<DESCRIPTION>S-8
<TEXT>
<HTML><HEAD>
<TITLE>S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on August&nbsp;5, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-</FONT> 8 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL INDUSTRIES LIMITED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Israel</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Not Applicable</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction or</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5 Basel Street </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>P.O. Box 3190 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Petach
Tikva, 4951033 Israel </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Teva Pharmaceutical Industries Limited </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 Long-Term Equity-Based Incentive Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full title of the plan) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Teva Pharmaceuticals USA, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>400 Interpace Parkway </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Building A, 4th Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Parsippany, NJ 07054 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Attention:&nbsp;Deborah Griffin </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(888) <FONT STYLE="white-space:nowrap">838-2872</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address and telephone number, including area code, of agent for service) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copy to: </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ross M.
Leff, Esq. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Kirkland&nbsp;&amp; Ellis LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>601 Lexington Avenue </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New
York, New York 10022-4675 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">466-4800</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company.&nbsp;See definition of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION
OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of securities<BR>to be registered (1)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registered
(2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering
price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>per share (2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering price</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registration fee (3)</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ordinary Shares, NIS 0.1 par value, deposited as American
Depositary Shares</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">68,000,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$11.465</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$779,620,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$101,195</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">American Depositary Shares (&#147;ADSs&#148;) issuable on deposit of ordinary shares of Teva Pharmaceutical
Industries Limited (the &#147;Registrant&#148;), NIS 0.1 par value (&#147;Ordinary Shares&#148;), have been registered under a separate registration statement. One ADS equals one Ordinary Share. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (this &#147;Registration
Statement&#148;) covers 68,000,000 Ordinary Shares, which may be issued under the Teva Pharmaceutical Industries Limited 2020 Long-Term Equity-Based Incentive Plan (the &#147;Plan&#148;), which was adopted on June&nbsp;9, 2020 and became effective
on July&nbsp;1, 2020. In addition, this Registration Statement covers an indeterminable number of additional Ordinary Shares as may hereafter be offered or issued pursuant to the Plan to prevent dilution resulting from stock splits, stock dividends
or similar transactions effected without the receipt of consideration and pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for calculating the amount of the registration fee, pursuant to Rule 457(h) under the
Securities Act, based upon the average of the high and low prices per share of the Ordinary Shares represented by ADSs on July&nbsp;31, 2020, as reported by the New York Stock Exchange. </P></TD></TR></TABLE>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (this&nbsp;&#147;Registration Statement&#148;) is filed by
Teva Pharmaceutical Industries Limited (the&nbsp;&#147;Registrant&#148;), to register 68,000,000 ordinary shares of the Registrant, NIS&nbsp;0.1 par value (&#147;Ordinary Shares&#148;), which may be issued under the Teva Pharmaceutical Industries
Limited 2020 Long-Term Equity-Based Incentive Plan (the&nbsp;&#147;Plan&#148;), which was adopted on June&nbsp;9, 2020 and became effective on July&nbsp;1, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with this Registration Statement, the Registrant is filing post-effective amendments to prior Registration Statements (File Nos. <FONT
STYLE="white-space:nowrap">333-206753,</FONT> <FONT STYLE="white-space:nowrap">333-212851,</FONT> <FONT STYLE="white-space:nowrap">333-214077,</FONT> <FONT STYLE="white-space:nowrap">333-220382</FONT> and,
<FONT STYLE="white-space:nowrap">333-168331)</FONT> to remove from registration the shares that remained available for grant under the Registrant&#146;s 2015 and 2010 Long-Term Equity-Based Incentive Plan, which remains in effect only with respect
to previously granted awards. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Plan Information* </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Registrant Information and Employee Plan Annual Information.* </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The document(s) containing the information specified in this Part I will be sent or given to employees as
specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the&nbsp;&#147;Securities Act&#148;). Such documents need not be filed with the Securities and Exchange Commission (the &#147;Commission&#148;) either as part of this
Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. These documents and the documents incorporated by reference in the Registration Statement pursuant to Item 3 of Part II of this Form <FONT
STYLE="white-space:nowrap">S-8,</FONT> taken together, constitute a prospectus that meets the requirements of Section&nbsp;10(a) of the Securities Act. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION
REQUIRED IN THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents, filed with the Commission by the Registrant, are incorporated by reference into this Registration Statement: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Teva&#146;s Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/818686/000119312520044221/d852939d10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2019, filed with the Commission on February&nbsp;21, 2020 (the &#147;Annual Report&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Teva&#146;s Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended
March&nbsp;31, 2020, filed with the Commission on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/818686/000119312520136212/d843470d10q.htm">May&nbsp;7, 2020 </A>and for the quarter ended June&nbsp;30, 2020,
filed with the Commission on <A HREF="http://www.sec.gov/Archives/edgar/data/818686/000119312520210627/d938521d10q.htm">August&nbsp;5, 2020</A>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Teva&#146;s Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/818686/000119312520164664/d933868d8k.htm">Form
 <FONT STYLE="white-space:nowrap">8-K</FONT></A> filed with the Commission on June&nbsp;9, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Teva&#146;s <A HREF="http://www.sec.gov/Archives/edgar/data/818686/000119312520114316/d838062ddef14a.htm">Definitive
 Proxy Statement</A> filed with the Commission on April&nbsp;22, 2020 (with respect to only those parts incorporated in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2019); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of the American Depositary Shares representing the Ordinary Shares, contained in Teva&#146;s
Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/818686/000089914012000392/t7562376.htm"><FONT STYLE="white-space:nowrap">Form&nbsp;8-A12B</FONT></A> (file <FONT STYLE="white-space:nowrap">No.&nbsp;001-16174),</FONT> filed
with the Commission on May&nbsp;23, 2012, as updated by the description of Teva&#146;s registered securities filed as Exhibit 4.33 to the Annual Report, including any amendments or supplements. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicate that all securities offered have
been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or
information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or
superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any
such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DESCRIPTION OF SECURITIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTERESTS OF NAMED EXPERTS AND COUNSEL </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INDEMNIFICATION OF DIRECTORS AND OFFICERS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Israeli Companies Law, 5759-1999 (the &#147;Companies Law&#148;) provides that a company may not exempt or indemnify a director or an
executive officer (each an &#147;Officer&#148;), or enter into an insurance contract, which would provide coverage for any liability incurred as a result of any of the following: (i)&nbsp;a breach by the Officer of his or her duty of loyalty unless,
with respect to insurance coverage or indemnification, due to a breach of his or her duty of loyalty to the company committed in good faith and with reasonable grounds to believe that such act would not prejudice the interests of the company;
(ii)&nbsp;a breach by the Officer of his or her duty of care to the company committed intentionally or recklessly; (iii)&nbsp;any act or omission done with the intent of unlawfully realizing personal gain; or (iv)&nbsp;a fine, monetary sanction,
forfeit or penalty imposed upon an Officer. In addition, the Companies Law provides that Officers can only be exempted in advance with respect to liability for damages caused as a result of a breach of their duty of care to the company (but not for
such breaches committed intentionally or recklessly, as noted above, or in connection with a distribution (as defined in the Companies Law)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva&#146;s Articles of Association include provisions under which Officers of Teva are or may be insured, exempted or indemnified against
liability which they may incur in their capacities as such, subject to the Companies Law. Articles 102 through 105 of Teva&#146;s Articles of Association provide as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">102.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of applicable law, the company shall be entitled to engage in a contract for
insurance of the liability of any Officer of the company, in whole or in part, in respect of any liability or expense imposed on an Officer or expended by him or her as a result of any action which was performed by said Officer in his or her
capacity as an Officer of the company for which insurance may be provided under applicable law, including in respect of any liability imposed on any Officer with respect to any of the following: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Breach of a duty of care
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> the company or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> another person; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Breach of a duty of loyalty
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> the company, provided that the Officer acted in good faith and had reasonable grounds to believe that the action in question would not adversely affect
the company; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Financial liability which shall be imposed upon said Officer in favor of another person as a result of any
action which was performed by said Officer in his or her capacity as an Officer of the company; including </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A payment which said Officer is obligated to make to an injured party as set forth in
Section&nbsp;52(54)(a)(1)(a) of the Securities Law and expenses that said Officer incurred in connection with a proceeding under Chapters H&#146;3, H&#146;4 or I&#146;1 of the Securities Law , including reasonable legal expenses, which term includes
attorney fees, or in connection with Article D of Chapter Four of Part Nine of the Companies Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">103.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of applicable law, the company shall be entitled to indemnify post factum and/or
undertake in advance to indemnify any Officer of the company, as a result of any liability or an expense imposed on him or her or expended by him or her as a result of any action which was performed by said Officer in his or her capacity as an
Officer of the company, in respect of any liability or expense for which indemnification may be provided under applicable law, including in respect of any liability or an expense imposed on the Officer as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Financial liability imposed upon said Officer in favor of another person by virtue of a decision by a court of
law, including a decision by way of settlement or a decision in arbitration which has been confirmed by a court of law, provided that the undertaking to indemnify in advance shall be limited to events which, in the opinion of the Board of Directors
of the company, are foreseeable, in light of the company&#146;s activities at the time that the undertaking to indemnify was given, and shall further be limited to amounts or criteria that the Board of Directors has determined to be reasonable under
the circumstances, and provided further that in the undertaking to indemnify in advance the events that the Board of Directors believes to be foreseeable in light of the company&#146;s activities at the time that the undertaking to indemnify was
given are mentioned, as is the amount or criteria that the Board of Directors determined to be reasonable under the relevant circumstances, including </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A payment which said Officer is obligated to make to an injured party as set forth in
Section&nbsp;52(54)(a)(1)(a) of the Securities Law and expenses that said Officer incurred in connection with a proceeding under Chapters H&#146;3, H&#146;4 or I&#146;1 of the Securities Law, including reasonable legal expenses, which term includes
attorney fees, or in connection with Article D of Chapter Four of Part Nine of the Companies Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reasonable litigation expenses, including attorney fees, expended by the Officer as a result of an inquiry or a
proceeding conducted in respect of such Officer by an authority authorized to conduct same, which was concluded without the submission of an indictment against said Officer and without any financial penalty being imposed on said Officer instead of a
criminal proceeding (as such term is defined in the Companies Law), or which was concluded without the submission of an indictment against said Officer with a financial penalty being imposed on said Officer instead of a criminal proceeding, in
respect of a criminal charge which does not require proof of criminal intent or in connection with a financial sanction. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reasonable litigation expenses, including attorney fees, which said Officer shall have expended or shall have
been obligated to expend by a court of law, in any proceedings which shall have been filed against said Officer by or on behalf of the company or by another person, or with regard to any criminal charge of which said Officer was acquitted, or with
regard to any criminal charge of which said Officer was convicted which does not require proof of criminal intent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">104.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of applicable law, the company shall be entitled, in advance, to exempt any Officer
of the company from liability, in whole or in part, with regard to damage incurred as a result of the breach of duty of care <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> the company.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">105.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the foregoing, the company shall be entitled to insure, indemnify and exempt from liability any
Officer of the company to the fullest extent permitted by applicable law. Accordingly, (i)&nbsp;any amendment to the Companies Law, the Securities Law or any other applicable law expanding the right of any Officer to be insured, indemnified or
exempted from liability in comparison to the provisions of these Articles shall, to the extent permitted by applicable law, immediately apply to the fullest extent permitted by applicable law, and (ii)&nbsp;any amendment to the Companies Law, the
Securities Law or any other applicable law adversely affecting the right of any Officer to be insured, indemnified or exempted from liability in comparison to the provision of these Articles shall not be in effect post factum and shall not affect
the company&#146;s obligation or ability to insure, indemnify or exempt from liability an Officer for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to indemnification and release agreements, Teva releases its Officers from liability and indemnifies them to the fullest extent
permitted by law and the Articles. Under these agreements, Teva undertakes to indemnify each Officer for monetary liabilities imposed by a court judgment (including a settlement or an arbitrator&#146;s award that were approved by a court), provided
that such undertaking (i)&nbsp;shall be limited to matters that are connected or otherwise related to certain events or circumstances set forth therein, and (ii)&nbsp;shall not exceed $200&nbsp;million in the aggregate per Officer. Under Israeli
law, indemnification is subject to other limitations, including those described above. Subject to applicable law, Teva may also indemnify its Officers following specific events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva&#146;s Officers are also covered by directors&#146; and officers&#146; liability insurance. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXEMPTION FROM REGISTRATION CLAIMED </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXHIBITS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Exhibits to this Registration Statement are listed in the Exhibit Index and incorporated herein by reference. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>UNDERTAKINGS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Registrant hereby undertakes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;To file, during any period in which offers or sales are being made, a post-effective amendment to
the Registration Statement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;to include any prospectus required by Section&nbsp;10(a)(3) of the
Securities Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to reflect in the prospectus any facts or events arising after the effective
date of the Registration Statement (or the most recent post-effective amendment thereof), which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement.&nbsp;Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may
be reflected in the form of prospectus filed with the Commission pursuant to Rule&nbsp;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the
&#147;Calculation of Registration Fee&#148; table in the effective Registration Statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;to
include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">provided, however, that paragraphs (1)(a)(i) and (1)(a)(ii) do not apply if the Registration
Statement is on Form <FONT STYLE="white-space:nowrap">S-8,</FONT> and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with, or furnished to, the Commission by the Registrant
pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that are incorporated by reference in the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;To remove from registration by means of a post-effective amendment any of the securities being
registered which remain unsold at the termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;The undersigned Registrant hereby undertakes
that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#146;s annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act (and, where applicable, each filing of an employee
benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers,
and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable.&nbsp;In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the
successful defense of any action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX TO EXHIBITS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description of
Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/818686/000119312518342203/d664508dex41.htm">Second Amended and Restated Deposit Agreement, dated as of December&nbsp;
4, 2018, among Teva Pharmaceutical Industries Limited, Citibank, N.A., as depositary, and the holders from time to time of shares (Incorporated by reference to Exhibit&nbsp;
4.1 to Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on December&nbsp;4, 2018) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d50479dex51.htm">Opinion of Kirkland&nbsp;&amp; Ellis LLP </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d50479dex52.htm">Opinion of Tulchinsky Stern Marciano Cohen Levitski&nbsp;&amp; Co. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d50479dex231.htm">Consent of Kesselman&nbsp;&amp; Kesselman, independent registered public accountants </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d50479dex51.htm">Consent of Kirkland&nbsp;&amp; Ellis LLP (included in Exhibit 5.1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d50479dex52.htm">Consent of Tulchinsky Stern Marciano Cohen Levitski&nbsp;&amp; Co. (included in Exhibit 5.2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney of Teva Pharmaceutical Industries Limited (included on the signature pages of this Registration Statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/818686/000119312520114316/d838062ddef14a.htm#toc838062_18">Teva Pharmaceutical Industries Limited 2020 Long-Term Equity-Based Incentive Plan (incorporated by reference to the Registrant&#146;s
 proxy statement, dated April&nbsp;22, 2020, relating to its 2020 annual meeting of shareholders) </A></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of
the requirements for filing on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Petach Tikva, State of
Israel, on August&nbsp;5, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA&nbsp;PHARMACEUTICAL&nbsp;INDUSTRIES&nbsp;LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eli Kalif</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENT, that each of the undersigned directors and/or officers of the Registrant hereby constitutes and appoints
K&aring;re Schultz, Eli Kalif, David Stark and Deborah Griffin, and each of them, his or her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of
substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign, execute and deliver with the Commission under the Securities Act any and all post-effective amendments to this Registration Statement and
generally to do all things and perform any and all acts and things whatsoever requisite and necessary or desirable to enable the Registrant to comply with the provisions of the Securities Act and all requirements of the Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and
on the dates indicated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Dr.&nbsp;Sol&nbsp;J. Barer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Sol&nbsp;J. Barer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ K&aring;re Schultz</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">K&aring;re Schultz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer and Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Eli Kalif</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Executive Vice President and Chief <BR>Financial Officer <BR>(Principal Financial Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Deborah Griffin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Deborah Griffin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Vice President and Chief <BR>Accounting Officer <BR>(Principal Accounting Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rosemary A. Crane</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Rosemary A. Crane</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Amir Elstein</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Amir Elstein</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jean-Michel Halfon</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Jean-Michel Halfon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gerald M. Lieberman</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Gerald M. Lieberman</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Roberto A. Mignone</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Roberto A. Mignone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Dr.&nbsp;Perry&nbsp;D. Nisen</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Perry&nbsp;D. Nisen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nechemia (Chemi) J. Peres</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Nechemia (Chemi) J. Peres</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Janet S. Vergis</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Janet S. Vergis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Prof. Ronit Satchi-Fainaro</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Prof. Ronit Satchi-Fainaro</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Deborah Griffin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Deborah Griffin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Authorized U.S. Representative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">August&nbsp;5, 2020</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d50479dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g50479n1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">601 Lexington Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10022 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(212) 446-4800</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Facsimile:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(212) <FONT STYLE="white-space:nowrap">446-4900</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">www.kirkland.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">August&nbsp;5, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical
Industries Limited </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5 Basel Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">P.O. Box 3190 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Petach Tikva, 4951033 Israel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are acting as special U.S. counsel to Teva Pharmaceutical Industries Limited, an Israeli corporation (the &#147;Company&#148;), in
connection with the filing by the Company of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the &#147;Registration Statement&#148;) under the Securities Act of 1933, as amended (the &#147;Act&#148;), with the
Securities and Exchange Commission (the &#147;Commission&#148;) covering the offering by the Company of up to 68,000,000 ordinary shares, par value NIS 0.1 per share (&#147;ordinary shares&#148;), of the Company (the &#147;Shares&#148;), which were
approved by the Company&#146;s shareholders at its Annual Meeting of Shareholders on June&nbsp;9, 2020, to be issued under the Teva Pharmaceutical Industries Limited 2020 Long-Term Equity-Based Incentive Plan (the &#147;Plan&#148;). The Shares may
be represented by the Company&#146;s American Depository Shares (&#147;ADSs&#148;) under the Second Amended and Restated Deposit Agreement, dated as of December&nbsp;4, 2018 (the &#147;Deposit Agreement&#148;), among the Company, Citibank N.A., as
depositary (the &#147;Depositary&#148;), and the holders from time to time of the Company&#146;s ADSs. The Shares being registered are issuable to certain employees, officers, directors and consultants of the Company or its affiliates in connection
with the grant of awards (&#147;Awards&#148;) to such employees, officers, directors and consultants, as applicable, under the Plan (the &#147;Awardholders&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this letter, we have examined the Deposit Agreement and such documents, records, certificates, resolutions and other
instruments, and considered such aspects of New York law, as we have deemed necessary as a basis for this opinion, and we have assumed the authenticity of all documents submitted to us as originals, the conformity to the originals of all documents
submitted to us as copies and the authenticity of the originals of all documents submitted to us as copies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon and subject to the
foregoing qualifications, assumptions and limitations and the further limitations set forth below, we advise you that (1)&nbsp;the Deposit Agreement, assuming due authorization, execution and delivery by the Depositary and the Company, constitutes a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Beijing&nbsp;&nbsp;
Boston&nbsp;&nbsp; Chicago&nbsp;&nbsp; Dallas&nbsp;&nbsp; Hong&nbsp;Kong&nbsp;&nbsp; Houston&nbsp;&nbsp; London&nbsp;&nbsp; Los&nbsp;Angeles&nbsp;&nbsp; Munich&nbsp;&nbsp; Palo&nbsp;Alto&nbsp;&nbsp; Paris&nbsp;&nbsp; San&nbsp;Francisco&nbsp;&nbsp;
Shanghai&nbsp;&nbsp; Washington,&nbsp;D.C. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g50479n2.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
legal, valid, binding and enforceable agreement of the Company, subject to applicable bankruptcy, insolvency and similar laws affecting creditors&#146; rights generally, and subject to
enforceability, to general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law); and (2)&nbsp;the ADSs, when sold or delivered to Awardholders in accordance with the Plan and the Awards granted
thereunder, will entitle the holders of such ADSs to the rights specified in the Deposit Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinions expressed above are
subject to the qualification that we express no opinion as to the applicability of, compliance with or effect of any laws except the internal laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission as Exhibit 5.1 to the Registration Statement. In giving this consent, we
do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not find it necessary for the purposes of this opinion, and accordingly we do not purport to cover herein, the application of the
securities or &#147;Blue Sky&#148; laws of the various states to the issuance and sale of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is limited to the
specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein. We assume no obligation to revise or supplement this opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is furnished to you in connection with the filing of the Registration Statement, and is not to be used, circulated, quoted or
otherwise relied upon for any other purposes. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ KIRKLAND&nbsp;&amp; ELLIS LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">KIRKLAND&nbsp;&amp; ELLIS LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>3
<FILENAME>d50479dex52.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g50479n3.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the N.Y. Bar Association </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">August&nbsp;5, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical
Industries Ltd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5 Basel Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Petach Tikvah 4951033 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Israel </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We refer to the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the&nbsp;&#147;<U>Registration
Statement</U>&#148;) to be filed by Teva Pharmaceutical Industries Limited., a company organized under the laws of the State of Israel (the&nbsp;&#147;<U>Company</U>&#148; or &#147;<U>Teva</U>&#148;), with the United States Securities and Exchange
Commission under the United States Securities Act of 1933, as amended (the&nbsp;&#147;<U>Act</U>&#148;), relating to the proposed registration of 68,000,000 ordinary shares, NIS 0.1 par value each of the Company (the &#147;<U>Shares</U>&#148;),
which will be deposited as American Depositary Shares, authorized for issuance pursuant to Teva&#146;s 2020&nbsp;Long-Term Equity-Based Incentive Plan (the &#147;<U>Plan</U>&#148;), as provided for therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As Israeli counsel to the Company in connection with the registering of the Shares pursuant to the Registration Statement, we have examined
originals or copies, certified or otherwise identified to our satisfaction, of such corporate records, consents, resolutions, minutes and other documents provided to us by the Company as we have deemed necessary or appropriate in order to enable us
to express the opinions hereinafter set forth. Insofar as the opinions expressed herein involve factual matters, we have relied exclusively (without independent factual investigation or verification) upon certificates of, and other communications
with, officers and employees of the Company and upon certificates of public officials. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"> -
 2
 - </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g50479n4.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>ULCHINSKY</SMALL> S<SMALL>TERN</SMALL> M<SMALL>ARCIANO</SMALL> C<SMALL>OHEN</SMALL>
L<SMALL>EVITSKI</SMALL> &amp; C<SMALL>O</SMALL>. </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In making the examination described above, we have assumed the genuineness of all signatures,
the capacity of natural persons, the authenticity and completeness of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, photostatic or facsimile copies, the authenticity
of the originals of such documents and the legal capacity and due authenticity of all persons executing such documents. We have assumed the same to have been properly given and to be accurate, we have assumed the truth of all facts communicated to
us by the Company, and we have assumed that all consents, resolutions and minutes of meetings of the Company&#146;s board of directors, of committees thereof and of the shareholders which have been provided to us are true and accurate and have been
properly prepared in accordance with the Company&#146;s incorporation documents and all applicable laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and in
reliance thereon, we are of the opinion that all necessary corporate proceedings by the Company have been duly taken to authorize the issuance of the Shares pursuant to the Plan and the Shares, when, and if, issued and paid for (or deemed paid for)
in accordance with the terms and conditions of the respective awards and the Plan will be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinions expressed herein are limited to matters governed by the laws of the State of Israel, and we express no opinion with respect to
the laws of any other country, state or jurisdiction or with respect to any matter governed by such laws. This opinion is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, to any other
matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinions set forth herein are made as of the date hereof and are subject to, and may be limited by, future changes in the
factual matters set forth herein, and we undertake no duty to advise you of any such changes. The opinions expressed herein are based upon the law in effect (and published or otherwise generally available) on the date hereof, and we assume no
obligation to revise or supplement these opinions should such law be changed by legislative action, judicial decision or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
opinions expressed herein represent the judgment of this law firm as to the legal matters addressed herein but they are not guarantees or warranties as to how a court may rule on such matters and should not be construed as such. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving this consent, we do not admit that we
are in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion shall be governed by the laws of the State of Israel, and exclusive jurisdiction with respect thereto under all and any
circumstances, and under all and any proceedings shall be vested only and exclusively with the courts of Tel Aviv in the State of Israel. This opinion is rendered to you subject to, based and in reliance on your agreement to comply with the
exclusive choice of law and jurisdiction contained herein and to refrain under all and any circumstances from initiating any proceedings or taking any legal action relating to this opinion outside of the State of Israel. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Very truly yours,</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Tulchinsky Stern Marciano Cohen Levitski &amp; Co.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Tulchinsky Stern Marciano Cohen Levitski&nbsp;&amp; Co.,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Law Offices</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>d50479dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> of Teva Pharmaceutical
Industries Limited of our report dated February&nbsp;21, 2020 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in Teva Pharmaceutical Industries
Limited&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Kesselman&nbsp;&amp;
Kesselman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certified Public Accountants (lsr.) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A member firm
of PricewaterhouseCoopers International Limited </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Tel-Aviv,</FONT> Israel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August&nbsp;5, 2020 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g50479n1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g50479n1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M!M.04$L>#GO]: .<\)WDOAKXGV;>*-LHUC3H8]*O2,)$H4?NL= >@)]<?WJ
M-[XH?\E"^'7_ &$3_P"A)0!ZKTH \6LYM=\2Z[XGUVR\+KJ^F:BC:;;2O?)
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M 4 % !0 4 % !0 4 % !0!B7/A32;NS@M987,<!D*$2,&_>9WY/?.XYSWYH
M2_\ ".C:C<W-S-;%9[D1"62*1D9O+;<AR#U![^PH L1^'M-CTNYTY8G\BZ),
MY:1F>4G@EF)R<@8Y/3CI0 R?PUIESK<>KR0M]LC*,&#D*2H8*2O0D!V'X^PH
M <WAS36@DA,3%)+P7K#>?]:&# _F!QTH HCP/HPMQ;XNS"LGFJANY"$?).5&
M>.6)XH L7OA/1[^ 036Q\H6OV/:CE08L@[>/]T?Y- "W/A73+N_N+R3[0);B
M,12A+AU5U ( *@X. Q_.@"72?#NG:*2UI'(9/+6+S)I6E8(O106)PH]!0 Z#
M0-/MK>""*)A%!<-<HI<D>8Q8DGUY8G'^% %)_!6AR3W4SVK,USOWCS&P"SAR
M5Y^4[E# CH1D4 76T"P=KAF1RUQ-%-(2Y^9X]NT_^.K]<4 4[GP;HMS=S77V
M>2&>:=;AW@E:,F15*ALJ1SAC]: %_P"$/T?+.(YQ,9/-\X7#B3=Y8C)WYSRJ
M@'GG&>O- "VOA'2;2^@O@DTMY#(91/-,SNS%-G))YPIP!0 Q_!>B2"0-!)^\
M656Q*PXDD$C]^[ &@"WJGA^RUB13>-<-&%"O"L[+'( <X90<'F@#5 P,"@ H
.. * "@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g50479n2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g50479n2.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M?#'P?KNIMJ-_HT;W3G,CH[)O/^T%(S0!H7G@KPU?Z1!I5SHMH]C;_P"JB\O
M3Z$<B@#5L;&WTVRBL[5&2"(;45G+8'IDDF@#E[GX5^";NZEN;C0(99Y6+N[2
M.2S'J3\U %[_ (0/PP/#_P#8(TF,:69/--N&8*6]3SDT 4K7X6>"+*[ANK?P
M_;I- XDC;<YVL#D'!..M $VJ?#?PCK6I3:AJ6BQ7-W,<O([OD\8[&@!T/PZ\
M)6VD7.E0Z+$EC=.KS1!WQ(5Z9.<\>E ":I\.O"FLV%E97VE+)#8IY=OB1PT:
C^@(.<?6@"7P[X!\,^%9WN-(TN.&X88,S,7?'H"Q./PH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g50479n3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g50479n3.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!),V\Z6<TH9,#'S(<'O],XH @7XD?$>Z\(VVLV?A!9)Q?2V\T"6\K$HJ@ [
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M]<=>: .1_P"$I\:>*?#GB;2]8\'13W>FJ&A*V[.CRK(N4&<Y;8Q(VG..G44
M2Z+\5O'LFO:?9ZYX+:RM+R=;<2O;30@.W"_,_'7M0!=\.?$'QUJFGZ_IE]X<
M6V\0V%GY]LK1,GG'./NL>?48.#0!!_PM_P 3KX*LM2/@^5]4N97*QK')Y;6Z
M*C-,!C.WYP,Y([Y[4 >M:1J,>L:+8ZG"I6*\MTG13U 90P_G0!<H * "@ H
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M4*GRCC@ ?6@#V[Q%8M)X+U;3[& %FL)8888QCGRR%4#\A0!J6R-':PHPPRH
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M)Q%JEF[ =PLRMC]* +GAI-<?Q1XHN=4\\6+7$<5@KDA1&J?,57MDGKW_  H
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M<D[GVJF?;A%'X4 6J "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H Y76_"UO>W^HZQ=SW+
MXLQ'!"ES(B1E0Q+84@$G(Z^E 'E?P>T=_&G@C7!J6HW[7@G,4%R+R4-$=@((
MPWKS0!Z*?&=_:_$FS\%-8P/YEI]H^U>:V0HSQMQU^7UH VKK6-1MY]946]L4
ML(!/&2[9DR&.#QQ]WWZT 4_AYXNN/&_AA=:FLH[-9)&18DD+D;3@DG H ;JO
MC)X_&$'A/1;-+S56A-Q.TLNR*VC]6(!))R/E'J.1F@"U<ZSK5E+=17&FVV(;
M)[E)TF8I(5(RA&W*GGW_ )T <YI7Q(OM3^&%[XS&EV\8M]Y%MYQ.X(<'YMO!
M_"@"/6/B9?Z3\,]/\8G2K>1;LI_HPG8; V<?-MYZ>E $_C3XB:CX)72KFXT5
M+VRND,EQ)!*0UNH9 3@CG_6*!R.?2@#H8_$OVN_T][ VUQI-Y927BW*NV[:A
M0$!<?]-!W&,$8H RM \<W7B3P_#KFEV5M<6\DZQ/;).?.@4OMW/QC('S%>..
MA-  WCBZC^)Q\(265NL2VOVMKLRD83TVXZ^^: ->SU;5]3:\GLK*V.GJ/]$F
MED93<G'7;CA,\!N_4#&"0#$\%_$3_A)M&UNZO[./3+S2)6CN+9G+F/ ZG@=P
MPP/[IH Z_2IKZXTR";4K:.VNW0-)#&Y<1D_PYP,D4 >(>&/'NB'6]9TGX@I+
M;:TUXX2[F+;85Z*B,.8@.Q& <YS0!Z7IBZWH>E:=I]EY>K1%+F>34+FY;E?,
M#1\A3N9E?V'RF@#+\%_$#6_&>B0ZO;:';1VIO?LLJBY9G0?+\X&S! W#(R.,
MF@!^A^/=6U[7/$>EP:;80OHEPMN9)KIPLS,S*N,(<9*^_6@!WB7Q]JGAS3_#
M=Q-HT7G:O,EO)"\Q4V\C=>=OS ?A0!>B\:S0_$!/!VI6$<5U<6INK:XAE+HZ
M_-PP(!4_(WKTH R]&^*/VCQM<>%M:TY=-N&=X[*X\TM%=%'9"!D#&2I ]P1U
MQD [#0-0O-3LYI[R""$I<S0*L3ELB.1D).0.I4G% 'C/Q5&K^'/%!\4:-=7,
M=KIUS;_:+5)6$3;AD$KG !*[3QSN% ':^/\ 7&UCP.RZ+=R1)=:;-J;3Q,59
M(8X]Z\CH6<H/IN]* *OP'FEO?A^;V[FDN+I[J16EF<NV!C R>WM0!U>G^--.
MU'QSJGA6(_Z580)*6SPY/W@/]W*?]]'TH S]>\:7VD>/M&\,0V%O*-51W2=Y
M2OE[0205P<]/6@"3P_X[74O$.O:%J5FEC>:, \KI-YD3QD9W D C@C(([T )
MX:\7ZEXQMIM3T73K>/24D:."2[E97N=O!8 *=BYXR<GV% &9XH^(VI^&?#VE
MZG/H<8EO;QK-[9[@@Q,&< [@N&&$S^- '7Z]K<?AOPS?:Q?;2MI"9&"G 9NR
MCZG _&@!=%UJ+Q#X:L]8TW:5NX1)&KGA21RI(]#D'Z4 <=X)^*/_  E6H76C
MWNG+I6LI&)K>&24LEQ&5#!@< ]"#C'0Y]< %J_\ B*=+T7P[)/8)-K&OF,6=
ME#*=HWA>6<C@#<,G']30!:UKQG/X3U72+?7K:$V>IR^0MW;L<0R<8#*W\)S]
MX'L>* -CQ;X@C\*^%-1UN5-XM(MRITW,2 H_%B!0!P'PNTB3QCH)\6^*YY-3
MN[V5Q;Q2N?)@C5BN%C!V@Y!YQV'OD ZEK>U\ _V_K]WJ%TVC?9H62"69I?)9
M2^53<> V] !GK[8P 0+XOUL^"/\ A+O['MQ9^1]K^Q^>?-\C&[=NQC=M^;;C
MVS0!1\1_%)-,T/P]K.DV<=]9:U*L*>9(8VC8]<X!Z'((]10!<\2>.+_P_P",
M?#_A\6%O.=7;:)C*R^400#Q@YZ^HH CD\=ZDOQ$O/"::?9@VUI]K-U).RKMX
MX("G'WO7M0!/KOBSQ#H?A2XU630(9;VWN3"UI'.Q\Q20%9&V\Y!SC'ZT )H_
MQ!3Q-X8T_6=$A@=IKF.UN8)Y"K6[LP'8'.,Y'3(]* .D\0Q)+X;U$2+G%M(P
M(X((4X(/8^] 'F7[/=S<:CX4U*\OKB6ZN5O3&LLTA=@NQ#@$]!DF@#N/'_BJ
MX\%^%9]<ALX[M8&17B>0H3N8*,$ ^M "Z;KNMWDVEL^G69M+Q-TCPSLSVY,1
M==RE1P<8SGN* */A+QO=Z]XHU[P_J.GPV%[I+ ;%E+^<I/#C('&,'_@0H AU
MWQQJFA>"=2\3/IMK+!:3^7%&L[ S)YHC#YV\9)R!SQWYH LR>*-='AX:U'I-
MH;5=+&H2%[AEY*EO+7Y3D@#D\=1Q0!4\->.]5USPWIWB.;1H8M*N5G:8Q3L\
MD C#\D;0""8\=?XA0!:T+QE>:_H5AK5A9VES:W<\<<D4,Y,EJ&<*2W')&<D<
M8]QS0!%:>.[B7XE:GX3N;2VAAT^T^UR7AF(!3Y.Q''W^N>U &S8:KJU\E[=+
M8P16*#-I)(S!YQC.XICY1U SR>N,8H S/AOXUN/'OA^75Y;".R1)V@6-92Y.
M ISG _O4 3?$O5[K1/A[K%[8W*V]XL.V%RP4@D@';G^+&2/<4 >>>!K^UO9M
M+\:6ES-INCZ=9&WU@/*T@N)]O4J"3QD,7;';WP >S6%_;:G8PWMHYDMYEW1N
M5*[AV(! .* /(#KEY\2/B]=^&4O;BU\.Z.KFXBMY#&;IT8*0S#G;N/3T7U-
M'=ZGX(MLZ?+HDLVF26MY!+)'!,R13QK(I=74'#< \XSGV)H ;8>,I?$'BG5=
M%T&WB>+22$NKR=CM\PY&Q%')QM.22,8[T 3>&?&2:WK>KZ#>6HL]7TIP)HED
MWI(A^ZZ' .#QP1QD4 =30 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % %#6IXK?1;UY7"+Y+CGN<' 'J?:@#R?\ 9XAFT_P_JMG>P2VUR]T)%CF0
MHS+L R >O2@#1\102Z-\=]&\17D4B:1+I[6QNE0LD<GS\,1]W.1R?7V- '5W
M4Z3V'B34@&2UFMA#"SJ5\W:C<J#R02^!ZXXSQ0!Q'PHU^U\+?"Q8M2ANDO()
M)G^RBVD,C\Y  QWH EM[6^\*_&"?Q3J=K*=*URP1)+B*-G6UF"I\KXR5&4X)
MX^8<\&@#O-2UJTOM U4VQ=X!:N!/M(C9BI 52?O'Z9].M 'C?AW1HU^ &J1W
M OXM4 E5;7[1,F23\H\D, <C_9YP?2@"?Q7'+<_L[:%IL$,LE^AA5K9$)D4K
MNSE>HQQ^8]: /3I)M,U37=(LYS'<6\^E7$,B,,J=S084]@2%;@\\&@#D_!WA
M'5? 7C;4[))9+K0DT^>XTXOR$9GCW1GW^5?KUZDT 8VJ>%+-;C3_ !/X&:\T
M7Q%/-$TND;&3=N8;]R'[JC))/W"!Q0 >+/#D?BWXTWEE++<06=QI7V=;N+<$
M68<A21PW/52>>G6@#J_A?XMU.X@E\->)8Y1JFGN88[LHQCNT4X#!\8)X_$8/
MK0!BZE806W[0]I-;QNNF7EJ'OV4'R6N$WE QZ9!2,X/?ZT >R4 >372>$?'W
MAB!_&5E_9FLB''FS1F"9CV>(X_>*>H49ZXQ0!J?"[2M0\,_##[/K3O$=\LD2
M3 JT<1^Z"#T)Y..V['6@#-^ 4<EAX!N;6\B>VG2]DD:.92C!2J8;![<'GVH
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M:)J=Y%_:-K&/E1PVY7QV!/?L2>S8H ]+\1S1P>'-1:1@H-O(H]22IP .Y]J
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M]!S1O_!1+_\ )- !]C\8?]!S1O\ P42__)- !]C\8?\ 0<T;_P %$O\ \DT
M'V/QA_T'-&_\%$O_ ,DT 'V/QA_T'-&_\%$O_P DT 'V/QA_T'-&_P#!1+_\
MDT 'V/QA_P!!S1O_  42_P#R30!>TV#6XI7.JZA87,9'R+;63P$'U):5\CVP
M* -*@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >??&52_@540%G
M^VVY"@9. X)/X"@#KFU_3@+QDN$D2SA$LKH05 .<#/0GY3Q]/44 <%I<E]X7
M^+#I>L'M/$]NLK-'(9$CN8QCJ0,*1P/P':@!?$/A>[E^(=[:6L)_LOQ1IK17
MSXR(I(B '^I5@H]SGM0!M_#"/55\'6G]MP^7>VRFQP>I2%V0$^YP?K@&@"G\
M2;*]EU+PEJ"H\FEV&II+>JO(09 61A_=4YR>V<T /T^&:]^,E_J]@V=)BTE+
M6XE4_NY9_,+  ]&*J>3VSCO0!D_"JTO7N/$3M)&+#^WKN5H&C.YR?+,<@;/W
M?E...O.>* )=.MKVX^,'BW[+-%'"ZV/FB2/=YR*OSJIS@'L>#Z<9S0!;UH'_
M (7CX:DQ\BZ?<*S=@3T!]S0 G@XRZ-XQ\9)KT@AN;N]$]M+,V!-;X(0(3UVC
M@@="?>@"G\28U6[\!K9 6\4.IQ,NZ(@0H  "R\8 XZXQ0!M:L-.UKP+>V-Q>
M3$"2"WN+VT4Y\_,6)5(^\%8J2?12.U #O <FO)<:I9:W>6NJ"V$2P:I;H%^T
M*0WRL!QN7CI_?H [2@ H Y_Q+_R$/#7_ &%!_P"B)J .@H * "@!& 92IZ'B
M@#S31?A_X>>T\4^%%-Z;%;N%O+:Y;Y/W2.I4]N21SGH* &^,OAYIUQX#MY+X
MWEWJ.BZ<8H6AF8&5@HP"/XN0/<T >@Z/I=OHFCVFEVID,%K$L2&1MS$ =SZT
M <-JWA#0?"FD>*]0G2_FTK4XE:XM8)2\A<NV2@)&#EQW[4 9GP]T/1M?\,Z[
MIEK9:Y;>';KRU6/4GV2>8"2[(03@<1_B#0!L:)\.=&TD^(/#L3WLFEW]I SK
M+.20Q:4$J>QP%_(4 <3XJ&B>&=(\'0ZC)>3S:=J5U%$F^3SI;99V1N5X)QY9
MP< @$#&: /3OASIB:5X%TV&.*YA216F6*Y8F2-78LJGZ @?A0!S7BKX=Z+<^
M.M&U417QN;^_W7)BG;:H2)F!QV!9$!^O')% %KQA\-=%O;G4?%*/?1:O'&;A
M##.0IDC3Y?E_X"!Q0!QGQ-CT'3O&=TFHZ3K4SW[6MT\U@25"H&4D#<!O.W;Z
M '/4<@'1_P#"(Z=<?#RUAD%]$NI:B-3@#2'?9EP6'_?,>?E.06)]<T 7?A3?
MP7YUR6P.LC3VF215U=0)!,VXR;<$C:?E/U)H ]'H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * *=]IL-_-8RRLZM93_:(]I !;8R8/'3#G]* +E !0 4 % %:
MWL+6UNKJYAA"37;J\SY.7(4*/R % %F@ H * "@ H 3 SG'- "T % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % "'.#
MM(![9H P/L?C#_H.:-_X*)?_ ))H /L?C#_H.:-_X*)?_DF@ ^Q^,/\ H.:-
M_P""B7_Y)H /L?C#_H.:-_X*)?\ Y)H /L?C#_H.:-_X*)?_ ))H /L?C#_H
M.:-_X*)?_DF@ ^Q^,/\ H.:-_P""B7_Y)H /L?C#_H.:-_X*)?\ Y)H /L?C
M#_H.:-_X*)?_ ))H /L?C#_H.:-_X*)?_DF@ ^Q^,/\ H.:-_P""B7_Y)H /
ML?C#_H.:-_X*)?\ Y)H /L?C#_H.:-_X*)?_ ))H /L?C#_H.:-_X*)?_DF@
M ^Q^,/\ H.:-_P""B7_Y)H /L?C#_H.:-_X*)?\ Y)H /L?C#_H.:-_X*)?_
M ))H /L?C#_H.:-_X*)?_DF@ ^Q^,/\ H.:-_P""B7_Y)H /L?C#_H.:-_X*
M)?\ Y)H /L?C#_H.:-_X*)?_ ))H /L?C#_H.:-_X*)?_DF@ ^Q^,/\ H.:-
M_P""B7_Y)H /L?C#_H.:-_X*)?\ Y)H /L?C#_H.:-_X*)?_ ))H /L?C#_H
M.:-_X*)?_DF@ ^Q^,/\ H.:-_P""B7_Y)H /L?C#_H.:-_X*)?\ Y)H /L?C
M#_H.:-_X*)?_ ))H /L?C#_H.:-_X*)?_DF@ ^Q^,/\ H.:-_P""B7_Y)H /
ML?C#_H.:-_X*)?\ Y)H /L?C#_H.:-_X*)?_ ))H /L?C#_H.:-_X*)?_DF@
M ^Q^,/\ H.:-_P""B7_Y)H /L?C#_H.:-_X*)?\ Y)H /L?C#_H.:-_X*)?_
M ))H O:;!K<4KG5=0L+F,CY%MK)X"#ZDM*^1[8% &E0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % $*WEL]V]HEQ$US&H9X@X+J#T)'4"@":@ H * "@ H * "@"!K
MRU2]2R:YB%TZ&182XWE0<%@O7&2.: %BO+:>XFMX;B*2:#'FQJX+)GIN';.#
MU]* )J "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % ')ZYX@N[*XUJ6!]L.C6T5P\>T'SBQ8LI)Y'RH,8QR3G.* +$^I7%GXWT
M_3Y-2S%>Q2L+:2WVI\H!78^.7QDD$G@$X% #=9\5PQ?8+72)8[VYOIC$&@(E
M$2JI=VP.IP, >K#/&: *,WBE[RWN)](O#);VFE&_$CH 9FW.%5@1\H_=.&
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M9!M_BQM)R#S0!IZY/?V<4%Y9O']GMC)+=1N0N^,1.0-V#M^?9SZ9H S8-?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M5=5U#2[.[WWNGD"YB:-D*9SC[P&1P>1F@!=!\2:3XFM)KK1[HW,$,IA=_*=
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M)]*N))X;A'DBD-O(BNJMM;!90.&.,=: +<NLV$&M6^CR3[;^XB::*+8WS(I
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MX]^: .E^*^G7NJ^#5M=/M);FX-Y ^R)"QVJX)/'M0 >,[759]6AF@BN9M/\
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M'B72KSP]J(@M((PC+]H,?E2;B3)@=>"O3GY: /4IE=-.=7)D=8B"0O+''H*
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M \'ZS:>,-*,T4BQ:=JNHW<LYSM>.55$>#W)SR.V#GW $^*'@7QIXE\7Z7?\
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M(!##YL ;NR].: ,9/#GBV+6]8MX&G274=6N'GG)/D/9O!B/GIN5@  /F'TH
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % #1$@E,H11(0%+8Y('0?J?SH =0 4 ,BBC@C6.)%
M2-1@*HP!^% #Z "@ H * "@ H * "@ H * "@ H 8D4<;NR(JLYRQ QN.,9/
MKP!^5 #Z &NBR(R.H9&&"",@B@!54*H50  , #M0 M !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M!8H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MAE49*!AD#UQ0 ^@ H * "@ H * &[U#A"P#D$A<\D#J?U% #J "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M%% $S*KKM901Z$4  55+$* 6.20.M  JA1A0 /04 +0 A56*DJ"5.1D=#TH
M"H)!(!*G(]J  *JEBJ@%CDD#J>G]* (4LK6.;SDMH5ER3O" -SUYH E:-&SN
M13N&#D=10 TP1$.#$F'.6&T<GU- #E1$.54 X X'8=J (DM(DOI;P ^=+&D;
M'/&U2Q'_ *&U #I;:"?;YT,<FWE=Z@X^F: &I9VL<WG);1++DG>$ //7F@">
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MO=ZCI9O[-2Y5(V$OELDAYSC(.0!T(QTH OV^L>-9=,U7=::&M[92[ XFE,&
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M!PN!DDG.,$'I0!Z,#D CI0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MC/8G/;&.* ,"7X?7>I7,VI:MJ\4VK/;0VHGM[4Q(R1RB4[TW'=N*@'D#' %
M&WX7\+1>&5U0PR)NU"\:[:.--D<9( PJY]N?7VZ4 <A'\('MK6.2UUY;?5X-
M3DU""_2S.4#XW1%=_P RG [_ (<F@#H+#P3)8ZQK-X+RVDCU-C,5:TR\4ICV
M,5;=PIX./PS0!4D^';?\(MX;TJ+4H_M6@RI)%/);;HY< @JT>[H0?6@!/$7P
MYDUZ:\==4AM!<Z=#8E$L\JFR;S=P&\<')&.WJ: -CQIX5D\6Z3;6*WZV?DW4
M=R7,/F;BASC&X8S0!G:KX&O;[7=<U:VUM;6;4M.%BH%KDQ8.=V2W/?L/K0!D
MW7@5K#1-7T1A->+KMYY\4]K!M%C*$7:[%G)QN0<\GUZT ;]]X+$WB;3]8M;B
M%5M[,V,L%S;^<LD>X,I'(PP(Z\]: *,GPXMY;S5;AY+4KJ:A;JW^SD0S_/NW
M,F[A\<;UP<_-UXH KCX7(NE3Z<-5D>&[LX;.Z>52[LD<A<;3NXX8ISG  /;D
M D_X5S,FM1W4.KHMFFM-K(A:V+/YC+ADW[P,9R1QQGOB@#I=7T635FGBF:UG
ML9H1&]K=6_F)N!;YQR/[WZ#D4 8-IX"NM'GBET76OLTD.C+I<;RVXE92C,RR
M<D#JW3&.* -SQ!X8L_%7AF31-99Y8I57?)'\C;Q@[AU .1TY% %7POX)TWP?
MX9FT31Y;B-)2[M<.P,I=AC=G &0 ,<=J ,*Z^&!U&TUI;_69);O4;2VMA/Y?
M*F#!5V!/S$LH)''I[T :Q\'S3:WX=U66\M8Y=)>>1XK>T\M)FECV''S?+CKW
MS0!0U7X=RZCXGFU9-66&*74K/43$;?<=]NNW;NW#@C';B@")OAM+')<RV6J1
MV;W<\$UU'%;D0SF-RS$IO^5G! )4CI[\ $%C\*OLVGZ'93ZN)(-+BOX2$MMI
ME2YSGG=\I7/H<T 7$^'URWAG2M(FU.U$FG75M,+B*QVF983\H8;^21C)S^%
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M:C=P^0K)#L2&/).T*#DY8Y))R3CIC% &?I/@>;2_ %KX4_M**5(59#=?9<,
MS$Y52Q 8;CAN<>E &XOAW3%\+GPXMOMTS[,;7R@3]PK@\]<^] &1X'^'>B^
M(;Q-):YE>[93))<.&;"YPHP ,#)[=Z )=,\("Q\8:_KT]U'<C5FMW$)@VF!H
M4*J0VXYSGT% &7IG@&_L/%R^()=:CN)E-U\K6I!VRD%1D/CY=O8 'GH230!/
MI/@O5=!AOX=*\0K!%=WD=WL-F"(SQYRC+8PY!. !MSQ0!H:WHD\_BWP_KUN
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M=F;:5WY&"W4-VYH J#X:3P^%T\*V^L1C0'@$<\,MH&D+^879T<,-I.<8((7
MQ0!W\4200I%&NU$4*H] .E #Z "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MCIW!S0!K:5K$^I7%Y";2.(VDZQR'SBV5:)9 P^4<_.!CZG/:@#7H * "@ H
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M]0N+L.Q?,R1+M)))QY:+U)SSF@"_0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MGJZF-!'LW G/!^<4 7UN[9SA+B)CNV<.#\WI]: %N;B.TM9KF4D1PH78@9X
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MA/0'TH %O[-R MW"<Q^:,2#[G][Z>] "I>VTD,LT4Z2QQ9#F-MVT@9(X[^U
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MTVG2:4S7";;>QBMKJ-1D3/$/W;#TQES_ -\^E '20F0PH9E59=HWA#D ]\'
MR/PH ?0 4 % !0 4 % !0 4 <HGAF]ET=M(N9H$M)-0ENY6C)9G5[AIQ& 0,
M<L%)YX!P!G@ IR^";N6SLH'N(7>R01*YS^_47$<NYQC[V(L=^78T 6+SPA/<
M^?$)XO*-U+<Q/R&&^!HO+/'W1NSGT4#'&: -'1M$N=*%^1)$&N$B$>W.%9(@
MF3QZK0!F2>#YC<27%JMM9^9/:SO;1,WE/)%+O9\8^5F'' YQSGL 0IX+O3:?
M9YY+65XKF"2.=BY>2..X6;# Y /RD<<$L3QTH LKX9N[+69=5MA;MMNIKE(@
M2N0T"QJO XY3/XT ;=_93ZG!912J(H?,66X02$-\HRJ@CT?:<Y'W?>@#GQX2
MU&U<QVD\#V4<EQY,$SL=L<RC.3@\J^XCK\KE>.M %_3?#4MC=V4YG39'9Q0W
M$2CB26,81\_1F[9X3TH Z&(R&)#*%63:-P4Y /?!]* 'T % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MV=25#8X) (R,^] '-Z=%K6KHMU<:I%#+:SRPLEK$RQR;74?,&)/\##KT;M0
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M.?X<;6&.I4CAA0!T] !0 4 % !0 4 )M7=NP-V,9[T * !P!B@!JQHI!5%!
MP"!VH 4C((/2@!D$$=M"L,*!$7H!0 ]E5E*L 1Z&@ "@    #I[4   48 P*
M %H * "@ H * "@ H * "@ H * "@ H *  @'J* $*JV,@''3/:@ 5%0850H
M]A0 A12P8J-PZ''(H 55522J@9.3@=30!%):P2A0\8(5PX'3Y@<@_GS0!-0
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M =99)$G<!CY6R%I.,#!. .,YYZ4 :]M>V]XJM;R;U:-95(!P4;.T_C@T 6*
M"@ H * "@ H * "@ H * "@ H * "@#.US5AHNE2W@MWN9%'[N"/[TAQG _
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M +UKK-G<DQK+^^218G3:V5<H' Z?W3G/3% &A0 4 % !0 4 % !0!DC78?\
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M7R]B\PI$0!D\%4'?O0 DF@W-UI,FG7^JR7$>P+'((PD@((*LQZ,P(!X 'J*
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MMS 31W:$^7T^T3^<_?L>![>M #KGP3!>2W+37C[;AKAF"( 1YJ*IP<]MH(H
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M&3@=\#F@"6@ H * "@ H * "@ H * "@"#[;:_:OLOVF+[1_SRWC=TSTZ]*
M!+RUDNI+6.YB:XC&7B5P64>I'44 3,RQH79@JJ,DDX % %>UU"RO<BTO()\#
M)\J0-QZ\4 237,%MY?GS1Q>8XC3>P7<QZ 9ZGVH =#-%/'OAE21,E=R,",@X
M(X]""/PH ;+<P0211RS1QO,VV-68 N<9P/4X!/X4 2T % #4=9%RC!ADC(.>
M0<$?G0 RWN8+N'S;::.:+<5WQL&&02",CN""#[B@"6@ H * "@ H * "@ H
M* "@ H * "@ H * "@ ^E !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M-6L$@>[-C?6RN?/79);M&P+;E(!^<,%/H1QC- &I<:KYNA/>Z?'+))("D*M
MX8/G:-RD;E ;KD< &@#EH8]4\-17FF6UI<&T^T07"/ KS%(G<"=0=HRV0SD
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MU:PTN76[Z>=FZ^1'\R1S29,A$>%#( N01D@8P3D@':T % !0 4 % !0 4 %
M!0 4 <K:Z'<7=W>6NIZO?WT=M(C0O*L<>"48$ QJNX88=<\@4 4[FXU.SUL:
M<=;OI#-(R1;8(RPR\+ G$>,!6E4DD?*/7D '2ZD7NE:QLM1-I?*%F&T*3MW=
MPP/RG!!QS[B@#"@L-3AU.U8:]>/-YQCD5K>';<1(Y.7;9D85BHVD9X]S0 [6
M;*^MM0OKC3]9O+=9('N);>*WA95(CVA@2A8L2J\$D<'CI0!J^';F:\T^2:2\
M>\C:9O*F>'RB5XXVX' ;<!GG ')ZD UZ "@ H * "@#(\2W$]KHI>W)#-<01
M.P."L;S(LC9[81F.?:@#&@M[Z[URYM+C4KXZ;<"XB6U,4:QQ!2@&UU0-_$<9
M;MCF@"Y-HM]%-%8V&NWMG;F#*E$B<QLC#NZ'.X/R#G[HQCF@!=)GOEUFUMYI
M&F$E@7N)"H7,BN%5L#@%@6Z?W1Z4 06VAW%Y<WMEJFKW]]%;NIA>58XRI:)U
M.#&JYXD[YY - %.^N-2LM8^PG6[YC<3O' J01LR;C$RDXCQM7,@))Z>IY !T
M6LRM)9W-K:7[VM_'$)U\M59L ^C @@D8/U[4 <==ZQK+74T>EZC>W5NMQ*9'
M-LH>.(&%CY?R -L+L "/F7< 20* +FKW.J:-J]C;RZ[?217=SM CMXW:-"ZE
M<XCY'WD/.0"#S@F@"6]BU?1XVCF\57SQJ4?[3)9Q.44AU(*H@W<[,=\\\C(H
M O:E-?W>FZ6$U*[TZ[EA$KM:11L7;Y!LVR*P R_MC')H R7EUR.>\DGU^^A0
MQ3[4%O$8XGCV8*GRRQ!).,YXXY- &KX3GOM2MX=5DU*[EMY4D5[6YA1#&_F$
MC!" D 97.<$ ''6@#IZ "@ H * "@ H * "@ H * &LB/MWJ&VG(R,X/K0 Z
M@ H * &-$CNCL@+I]TXY% #Z "@ H 8\22,C.H8H<KD=#ZT /H * "@ H *
M"@ H * "@ H * "@"*YM8+RW:WNH4FA?&Y)%#*<'(R#[T .$4896"*&4;5..
M0/0?D* 'T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 0I:6T=U)
M=)!&MQ( KR!1N8#H": )$1(T"1J$1> JC % #J "@ H * "@ H * "@ H *
M"@ H * "@ H ;L3S!)M&\# ;'('I0 (B1KM10HR3@#').2?SH =0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 -V*)"^T;R,9[XH =0 4 % !0 4 % !
M0 4 -DC26-HY$#HP*LK#((/8T *H"J%&<#CDYH 6@!BQ1I*\JJ [X#-W('0?
M3D_F: 'T % #=B^9OVC?C&<<XH =0 4 % #2B&0.5&]00&QR <9'Z#\J '4
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M%S,UJ4D%S&Z1NI4#):/>&'/W<9Y]B.HH UJ "@ H * "@ H * "@ H * "@
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M*S:%C& P,[R("W/W250=L9Y% '1VUPMS#YJ!@NX@9[X)&1['''M0!+0 4 %
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M8R%_O%3QC.05P?3([&@"W=^(;:TTRUU!;6^N;>Y4.GV>U>1E4KN!90,KQZT
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M** *.M:"FLQ[&O9[4,4WF$(6(7=QEE;&=W48/'!% %^6*X:[MGBGV0)N\R/
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M\*3^% #;N_MK%[=+B0H;B40Q?*3N<@D#@<=#UH LT 0S7=O;'$TR1X1I"6.
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M "@ H * "@ H * $(!!!&0>U "T % !0 4 (0#C(Z=* %H * "@!,#.<<^M
M"T % !0 4 % !0 4 % !0 @ !)  )H 6@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MEB-95C(^4MG+<?PT 9__  D6H':ZZ!,8)HM]O(;B,>8WE[]I&<J>&&>1D>]
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M-A&7 7=\N2 20..: +@FB)P)$SG;C<.OI]: )* "@ H * "@ H * "@ H *
M$) (!(&>![T 4[?5K&ZO;BSAN UQ;D"1,$;2<^O7H>E %Q65ONL#QG@]J #<
MHW?,/EZ\]*  LH."P'3OZ]* #(SC(SZ4 (9$"ABZA2,@YXH 5G5?O,!QGDT
M)O7.-PSG&,]\9_E0 Z@ H * "@ H * "@ H 0D @$@9X'O0!3M]6L;J]N+.&
MX#7%N0)$P1M)SZ]>AZ4 7%96^ZP/&>#VH -RC.6 V]>>E "%U 8E@ O7GI0
M,ZK]Y@.">3V% #([B.1IE7(,3[&W#'. >/7@B@"0,&&5((SCB@!: "@ H *
M"@ H * (+F[@LX&GGD"1JP4GK@D@#I[D4 ):7UK?64%Y;3*\$Z+)&W3*E=P.
M#TX.: )R0%W$@ <YH -PSC(SZ4 )YB8SO7 SW].M "Y (&1D]!0!']HC^TK
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M8E4,"1@BY\T'[O\ =X^M '3^(]$DUJVM5@G^SW%O.'$G<(04D'U*,V/?![4
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M&P''/W^^* .=O/!6J_V==V,%Y!=0RRS&-[EB)$C:W6)%+[6)P003P2,9/7(
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MO0 W4]7US3+B:,G3S$ YBD</DY1C&&P>NY&!QUR,8/% &]J#7B:=(UD]LEV
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MR.9  JNHQ(/4JW4'J.E #Y[G6+C0(+Z"2Q@O;>1S-YCN8&"[E8C&"1T(S_\
M7H RX_%&MW.LMI4<%A!<B%V'FERK2"*-M@Q@[@7.1W4J1T(H N7&H>*K9KCS
M(=* \AYX!NDR-C)E7^JL1D=P."* )-%\176I>([W3IH[>.*W$NPJ3NE"RE-R
M^PQAAU#8ZAA0!TM !0!&UO"\RS-"AE085RHW >QH /L\ _Y8IUW?='7UH 06
MMNN=L$8^;?PH^]Z_7WH 4V\+2>8T2%_[Q49H 1K:W=R[01LYZL5!/3'\J !K
M6W8@M!&2  ,J. .@H CET^TF$8>W0^6ZNO&,,IR#^!H G\M-Q;8NXC!..2*
M(_LEME3]GBRGW3L''.>/Q _*@"0QHP(**02"<CN.A_04 .H * "@ H * "@
MH * "@ H * "@ H * "@"-X(9&#21(Y'0LH-  \$4DBN\2,Z9"L5!(SUQ0 )
M!#']R)%XQPH'%  EO#%GRXD3/7:H&: &+9VJ@!;:( #  0>F/Y4 +]CMLY^S
MQ9]=@],?RH 4VT!96,,>Y0 #M&1CI0 V>SM[D()HE<)(LJY[,O0_AB@"7RTW
M%MB[F&"<<D4 1_9+;*G[/%E/NG8..<\?B!^5 $AC1@044@D$Y'<=#^@H =0
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M,\DQ0%Y$5&SR"%)(X^K&@".;3+"XOH+Z>QMY;RW!$,[Q*9(P>NUB,C\* +5
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MH7P"JJS'./N@,,GI^8R ,U?7QIATDQQPO'J,YA62:;RE3]T\@)^4]1&1]2*
M*%CXSANS8R26XM[6XANI7F:3(7R'525P/F1MV0W<8XYH UCXBTE8ED-X@4L4
M.005(8*=PQE<,0#G&,CUH I:9XLL;NVG:[=+6>&>>)HMQ;(CN&A!!P,Y*KP.
M<L!W&0"[#X@TJXG@@AO%DEG4LB*I)P"0<\<8((.<8/'6@"SJ-Z-/T^:Z\LRL
M@^2-3@R.>%4>Y) _&@#.G\3V4?AJ/68CO6:V,\,1!#-A=Q!P"1CH3CCO0!9L
M=;L[R!6$@$H\M9(P"2C.H8#IZ$4 :5 !0 4 % !0 4 % &%KGB%]'O[:U%O
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M5MHX[9HI_FQ*TSR*H''0E!A@2#NH VX9XYU9HFW!6*$XQR#@_J* )* "@ H
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M=\I^Z"<'[HH ;:Z%K<5G##+J-DQ%U'(^+=R%A1E81IER<Y#?,<_>Z<4 =/0
M4 % !0 4 % !0 4 5M1MGO-,N[6*7R9)H7C63'W"00#^% #KJW%Q8S6PPOF1
ME <<#(Q0!G:/IVH6$=T]Y<02RR,?*2)&"QKEF )9B2<L>>!C P,4 -_LZX:2
MRO&C"WC3)+<@2$HI$;(2H)P.N./UH HWWA$W]A!8RWA%NCQ%@HP1LB* J?X3
MNVL#V*]Z -EK&231DM;AHKFX2( LR;4=P/O%1T&><=J *NF:1=VUM:?;KQ+F
MZBF,LDBQE0WR%  "2>A'))S@^M &C;VWV>:ZD!'[^428 QCY%7_V6@"Q0 4
M% !0 4 % %6&U>/4KFZ:7<DJ(JIC[NW=G\]U &7>Z)?3ZLEQ;7<,-NTV^<&-
MF=TQ&"@PP'/E\D@\'B@#7W7/VXKL3[+Y8(;^+?GI],?Y] #$ET"__M*-X+Z!
M+$EO/A:$EF!D9_E.X <,5/!X)H NWMIJK2R3V-S:)/N"Q>?"SJD>!N& RG<6
M&<YQ@#CO0!%_95P--T>SE,<@MG43B,;$90C+P"2<9*\9/2@!^M6&HW43)IDU
ME#YT9CG-S \FY<< ;77'5O7K0 R;2KN2^/[\"VN-QN0HQN&R-<#Z[#SV!(Z\
MT 3:MI<M_)%)#)"C1QNN)8RRMDJ1D CC<H)'<<4 +:Z?=6FB+9QS0QW/),D<
M>U%+,2VU23CJ<9)[=: (K?2;G[<[7<EJUE'"UO;PQ0LK+&Q7(9BQSPH' '>@
M!--TBYM-4DNIY;9U\LJICA*R,6(+%VR0>1P !@<4 ;- !0! E]:23F".ZA:8
M=460%A^% $S,J*68A5 R23@ 4 ,@N(+J(2V\R31DD!XV# D'!Y'O0!)0 @92
M2 02IP<=J &&>%9UMVE03.I98RPW$#J0/3D4 *DL<CR(DBLT9VN <E3@'!].
M"#^- #Z (I[FWM4#W$\<*DX!D8*"?QH 6"X@N8]]O-'*F<;D8,,_A0 0W$-R
MA>"5)4#%2R,",@X(X]#0 _<H8+D;B,@4 ,:XA2=(&E199 2B%AN8#K@=Z )*
M "@ H * "@ H * "@ H * "@ H AGNK>U53<3QPACA3(X7)].: )J "@"!KR
MUC,@>YB4Q#+@N!L'OZ4 3 @@$'(H 6@ H KI?6CLJI=0LSDJH$@))'4"@"6*
M:*9-T4BR+G&5.1D4 /H * "@!H=#'O##9C.[/&/6@!(9HKB%)H9$DB<;E=&R
M&'J".M #Z "@ H .E $$-[:W+LD%S#*R]0CAB/RH GH 8)8VE:)74R( 64'D
M YP2/P/Y4 /H 9YL?G>3O7S-N[9GG'KCTH )98X(S)+(L:#JS' 'XT )#<0W
M,?F03)*F<;D8,/TH %N(6EDB65#)$ 74,,IGID=J "&>*YA6:"5)8F&5=&!!
M^A% $E !0 4 % "!E)(!!*G!]J &1SPRR21QRH[Q'#JK E3UP?2@"2@ H *
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M[2&1@R]<X8XQR3VQ0!>M&U@WMG<2:K(\,ACE>W," ;9%.4SC/RE<@YSS@YH
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MH WJ "@ H * "@ H * "@ H * "@ H :8T,HD*+Y@& V.0/3/X4 .H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@!" 001D'J* $
M1%C1410J*,*JC  ]* '4 % !0 4 % !0 4 % %>ULK:R#BWA6/>Q9L=R3G^I
MH L4 % !0 4 % !0 4 % !0 U(XXRQ1%4N=S8&,GU- #J "@ H * "@ H *
M"@ H * "@!&4,I4C@C!H 8D,4;ETC56*A,@8X&<#Z#)_.@!SQI(H5U# $-@^
MH.0?S% #J &&*,S+,44R*I56QR <9'XX'Y"@!] !0 4 % !0 4 % !0 4 %
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MRF[LXY3MW*L<TZQ]<CD@L1U[9ZB@#0T[6;75%4VPDY,BD,N"AC?8P;T.[(_
MT :- !0 4 % !0 4 % !0!@CQ&@\6C1F1/*>,JDN[DS* S)C_<8$'_9;TH :
MWC#34D$1BNO/+1JL/DG>?,#%./X<[&X;!&.0* )+GQ;I=I%++*THBCCF<.$R
M'\DXE QW7GCO@XS@T 6$U?[9I^HRZ?;O+=V;/%]GD^0F4*&"YZ#(*\^] '/P
M^+[B>&SEMY89R][':SP?9GBFB)1BR,C-\K9 P3Q@_C0!K)XOTR1+&1!<,E\@
M:W;RB-Y*,X49Y)VJ?8' )R10!/9>)=.U%XTM7:0RQ0S)@#YDE#%&'/HK9^E
M%^^NX["QGNI/N1(6QGD^P]STH Q]*\2K>:-;2W"*NHO,]H\$)W#ST#;@N2/E
MPI8$D?+CUH B\.^*DU/1K&6[4K>RVD%RZHFU3YAVC;D_W@1CMQGJ* .EH *
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M3\N>#F@!\7BW2Y9+6)?M0EN2H2)K617&69,LI&5 9""2.,@G (- &Y0 4 %
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M$PG C##$7G9\PKQD9RW7.-QQB@"]#HT%O%J2)-,#J$ADE;< P8H$RI XX44
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M%(J6@#)-'C[ZE2  >V#B@"#1=(DTJ&19]1GOY7;/FSJBD#DXP@ ZECTSS]*
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M!-ON(0ADC12Q0.<+G XR0?P!/04 3R3)&\2-NS(VU<*2,X)Y(Z# /)]AU(H
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M.U)W7V1O6X)ER-^#^ZQGL>G)H <;/Q1-+-B"_B1YK5POVL?*JW9,HW;^\7H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * $*@D$@$CI[4   &<
M#&>M "T % !0 4 % !0 4 % !0 4 % !0 4 (JA5"J  . !VH 6@ H * "@
MH * "@ H * "@ H * "@ H * $*AA@@$>AH 6@ H * "@!,#.<<^M "T % !
M0 4 % !0!RNFWFI76LZI!)=7AA@U'R49$AV(@A1\-QNY)(S_ +0YH IZ5XP>
MUT?2#J(:=KA4$MQN&X%F< E0.!\G4XZ\9P0 #3T/5KK5-=O"^8[-]/M+FWCW
M [1(TV2>."0JY&2..#0!AQ>)M6MM%U>SN+E9=5!D>QF**-T1WX8@  E/+?/J
M%7/+4 :*>)YK5[>W-O-=W4L=J@+2*BL\BNV[@<<H0>/3 H GO/%033]8W6DD
M<^G+,9T20!U5$#!E)&/F# C_ .L10!HV.MI>:S=Z;Y1BEMADJY(=AG 8*1RI
M[,"1V.#Q0!!XIU*]LM.$6E MJ4V3$!$9  HW'( )P>$SV+B@#,UOQ4;CPU-<
MZ*S>8U@+T2DA3&C' X(.3PV1VP>0<4 ;-EK@O-3N=/\ LQCN+>9HY%+_ , 5
M6$@XY!WJ/S]#0!KT % !0 4 % !0 4 % !0 4 % !0 4 % !0!R?BG7;G1-<
MTS;.Z6<MO.TP"!D0JT0$CG&X*N\DX_'CD %N_P!>_L".R@F:2_#^6K3ED#MO
MD6,-M4 8RP).%'H2>* *7_"7M)!9WCV$L44OVAHU693N\I'R&&.Y4XY]/I0!
ML:+K?]KM=(UL8'@*<;]P*NBNI^N&P1[=Z ,FU\1W%QK]Y:R,T=I<P.VGOY17
MF,D.=Q&&SE67&?E!- %32O&-VFDZ/!=6+3W]U;6K*_F@+(94;YF./E.8VR #
MU&,]  79O&B037$36#%HGC4;)0P.Z?R>2.,AL' )]#@@B@!L/C>(Y%S8O"?W
MJ+B0,&DCN!;LO3@%V7!],D@8H L'Q='#>?9KJS:%DN)+65]^4658A*H!QSN0
M@@\=".O4 9'XG/\ :5Y8):2/J N3"D#3*%)6WCE.UL<#$@'UST'0 ATOQ%<#
MQ-?Z?<AY89M1\BW8LN8O]#BFVX'4<OSD\D=>H -_6+TV&F2S1@F8XCB 0MEV
M.%X')&3DX[ T <_IWBB:XT.UMW4OK1\VWE4CR\21+\[X(X!^5@,='7MG !)X
M>\22W&GZ7;749>^FL;6<.S >?YB_.PX_AVL2/IZB@#JJ "@ H * //[/Q#J\
M-UILES=3R6TVJWMG*TL<0C*)),L:@J P?Y$&6PIPV3DB@#4MO&K7=W!9PZ:6
MN)IA$N)ALYA\T'=CD8!&0",]"1S0!0U3QMY9MI"6LXH+B&2<JRNKPN)>"P&,
M@Q'.TD?[1YP ;OB.^OK7PL]Y YM;H-%_JRKXW2*",L,'@GM0!7NM<N=',4<M
MO=7,ES+(D:W#1IMV1&3J@Q@[3ZG/Y4 )-XTMHO*<6<YA:-)6;C<B-$TN_'=0
M$(S_ 'N* *6K>(-0D?3/)2>P$EU)&QP"LR?8YY%(W+GAD';&5[B@!^G^,)8[
M*QM+NT>34IK:"2,*Q83!XW;)VKD']T^1@]N<'( +:>+69;N1]+FBAMGAB<NX
MW*\HB*Y S@ 2Y8YXVGK0!L:1J#:IIR7;6[0;F8!6.<X8C(]0<9![@@T 8NH>
M(9[/Q9:09/\ 9>\6<Y\IL+.X#(2^,8^ZN,]91Z4 4YO%-VVN0W-K"\NG#3KZ
M98%8;IVAFA7.,<'YGP,\Y'0T =3I]_'J4+3VY5[?(\N56RL@P#D>V21^!H M
MT % !0 4 % !0 4 % !0!F:WJEQI%D;J'39KY$!:4121H44 DM\[ 'I0!6;4
M=8LG\R\L$FMY)TB06[ /&&D=0S;FP0%\K..<ENO2@"QHVL-JT7F&S>W'EHXW
M2(W+ Y7Y2<$$<YH ;>:K?6\UQ%;Z+/=M"R;1'-$OF*P/S#<PQ@@C!QZC- %*
M3Q!J$T<8M]#O$6YB$EM,9(<.WE^9L(WY!X9<],CKWH GM]>O)]ZG0KF*98G8
M1O-%\SJ1^[R&(R00<].N2"* (].\5PZEK2:9%93+(8?.<LR#8A52IQGG)8KQ
MD@CG@@T .DU^]6[GMXM!N9MN[R72>';/M8!@,OD$9_B Z8]* "+Q%=N;5WT"
M]CMYG\J20R0GR7\PQX8!\D9 .5SP: -Z@ H * "@ H S=;U2XTBR-U#ILU\B
M M*(I(T** 26^=@#TH JMJ.L64GF7EA'-;R3I$@MV >,-(ZAFW-@@+Y6<<Y+
M=>E %C1M8;5HO,-F]N/+1QND1N6!RORDX((YS0!%<ZW=Q:I/8P://<F)-X=)
M8P"-A(SEAC+ KS]>F2 "LWB2]1=[>';T(\?F0L98?WAV[BF-^5;&[KQ\O7I0
M ]?$D\CS10Z)>22+N\G#QA9\%<[6+8!PV<''1AU%  GB.[86TCZ!>QV\K>7)
M(98?W+^88\, ^3R <KG@_6@!=%\2KKUC>7-E92G[/\H1G4%I-N3'U^4@D#G@
MY!!(- #3XAU!XQ);^&[V<%(Y $F@!*NN>[@9!!4C/N,B@"!/&4<][+9VFG3S
MSQQ>;M\R-,@[?+QN8?>+$>Q4@XH VM+OWU"U:26SELY4<H\,K(Q4CW0D'J.A
MH NT % !0 4 % !0 4 % !0!A7&K:F=5?3+;2S%)P\=S-(C1/&'0.=JMN!PQ
MQD=10!$?$%]9"."_TLBY"QAY$E18F9HV8D;FR &1EY]0>: ->2]:/2&OC;2!
MU@,OD,0&SMSM)S@'MUQ0!E+XBOG4!?#MZ)MSH\1EARKA ZC(?!W \'/!X.*
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MECE^S?/$8RC;VR-@(3OVW'\S0!-<:58W0NQ-;(WVR(0W!Z&1!G"DCJ/F;\Z
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MD9ZT 6+33K2QAMX;2$00VZ>7%'&2JJO'&.G84 6J "@ H * "@ H * "@ H
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M(IW,7W)U17>)B"R!B0"<$CG:>_:@!D=_%)JESIX5Q-;Q1S,2!M*N7 Q^,;4
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MF\S86'EN4;<I7D?7K]: ) 0> : %H * .6U3P_J=]))J$=Q$FHPW<<UHN_\
M=A$XVLVS<-RM(#C^^: *)\./>-KATPK#%*QD@26%XU6X.!-R0#L8(HW*/XWQ
MF@".;PCJ<JQ2VL5G8-]END:%;F20"262%\;BH)5O*8,1C&_@'J0"]I'AJ>RU
MVQU)K"TME6&X62*.=Y3&\CHV59E&<[7S]W&[OR2 0:GX4U&_O-5D7[.@NKV"
MY@E^TR9B\M8QN,>W:S90D G'3F@ L_"-S9) QM;"7%]=S3P9^66.625H\G;]
MY1)C!&,%L4 5;;P=JUK-81RO;7R6UQ;3"XGD;S%5(!$Z#Y3D$@L.?XSGU( V
MT\&ZM9:6+>*'3&NFTVULS,[$B-HWDW,N4.3M=2N1U49Z4 6+7PAJ%AK%G<V4
M&GPV%O##!]B:1G5E1YB7R4SO D4@]R7!ZA@ 6M!L6TNWN[JPM/.M?/Q80O$T
M+Q12,K2  KD#>6P" ,*HX'- &QJNF3:I=VT;NJ6$:NS@$%F<C:!M*D%=I?\
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M\6=S(Z2,8VC1 I_O!G9F^IW_ *4 90T[7))$C:XL4LA=M,T;P,\A G+KA@X
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MWVH3I&8;CS@GSY:+,Q8!?]EP0Q!/# X^]P =50 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S>
MBWHMY_$<EU=/Y46I>6AFE8J@,46%&<X&YCP/6@#*M?%^JW<UI;JEF)+F>&-9
M/+?;MD@>0$#<#P4[X)!Z*: 'Z1XVNM3N/#Y\FW$6IK$LJH26A=[5KCJ?]T#
M!X8$D=* +^K6V?%NE0BZNTBNTN#*B74BJ2J(!@ X&.O'<D]Z *1\7:B_]HFV
MAMIUMH6N8R@;YT29D8#)!8[5.#@#(XR,&@"Q<^*+H1WDUJD#Q6]J+Z-2IS<0
MEF "G/!PF<X/WTXH TO#NI7FJ6MQ<79MU5;JXMHUC4@_NII(\G)/4(#CMSUH
M S_%E[J,3I)IOG$::HO)UB*_O%!YC.3R"@DX'?8: *6JZW-J6KV4=E<)';VV
MJ00G&[,H>#S W! *?.!C'53S0!M>'-:N-7MV:YCCBFMR8+E%!PLZL0R@D],
M$>H8&@#=H * "@ H * "@ H * "@ H * "@ H * "@#E?%RWRRPW-G+YT=O;
MRM<6(G:%Y$.W]Y&XZ.N.,\?-U'6@#(7Q//IVL7]TDB&QNKP*!<EQY0&G^>#G
MG:/W9R #]XGM@@%ZR\27E[K=K975O"&BU)[5F *G_CS$P;&XX/SE<'/KP>
M3RW;R:KXF^VB1AI\:-;0K,T>8C%N+@CH2_F+N[;* ,Z[\:7MD%2&.WD18F7Y
MBS,CK:^> Q^7)(QP!T8'(/% %ZW\3ZA-JK:4RVR7+7!CCF*-Y>/LZS8(W9W?
M,1UZ*3[4 06'C+4+RYTYVM8(K>Z:V#1$$NOG1,_WLXX*CMR#VH ZC5;UK/3)
M)X 'F8!(%'.YV.$'TR1^% ',:9K=[IT$.A7;N;];_P"QI/=D,3$R/+&[;3R2
MJ[.HRPH @\,:[?6^F:+8SE97OK4FWE;<Q:57Q(&)/92&'<@-Z4 =V"",@YH
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MP(+<=R": +'V:WW2MY$>9AB0[1\XQCGUXH KC1],$L4HTVU$D( C;R5R@'0
MXXQDT 6&MH'^]#&?G$G*C[PZ-]>!S0!+0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % %>XL;.\*FYM89RHP#)&&Q^= "/IMC([/)96[NQW%FB4DG&,].N./I0
M R'2=.MF5H-/MHF4[E*0JI!QMR,#T 'TH DN;"SO&5KJT@G900IDC#8!],T
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M^18_E&/E7.T?09- $U !0!F7.MVUKKMGI,BOYMTC%7Q\H8 D*?<A7(_W#[4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MJO0F4LK*>V5;Y@."P!]<@'14 % !0 4 % !0 4 % "!E+%0PW#J,]* %H *
M#/I0 BLKC*L&&2,@YY'!H 6@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * .6&GZK?:AJ&FWVNRF-42:)K6+[.\8?S5VE@WS8P#VZ"@"IK&K:EI>H-
M;2Z]:P_:))([16@3>S,JF-0"PW[3D9'7<,CO0!T^H-+/#)966H16FH,F]&9!
M(5 (R=F1D=OQH X^[US5+1[>QNO$=E;WTVZ.$&U -PX>5!L4OR<^5P,\\]":
M -W3+Z?4)-;LX-;M;FX@?RTDAC4_97*_=8 \E6!.#@]CZT 8UUJ^LZ1(\5[X
MATP/!)Y>9[<0B<D(Z(OS_?(\Q1C/KCC! -70KS4KG4Y)9=4M[W3K@W!@6. *
M8O+E"@;PQ##!/8=* .DH * "@ H * "@ H * "@ H 9%%'#&$C0*N2<#U)R3
M]<\T /H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * # SF@!-J[MV!GIG% #3#
M&9Q,5'F!2H;T!P2/T'Y4 /QB@ H ,4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
J % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g50479n4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g50479n4.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M2@#S^>#QC<:O+H4O@FVDTY]0D U1F7<L3W&\R 9X.,'\!0![-0 4 % !0 4
M% !0 Q88DEDE6-5DDQO8#EL=,GO0 ^@ H * "@!DL4<\+PRHLD;J59&&0P/4
M$4 .15C1410JJ,  8 % "T % !0 4 % !0 4 % !0!'/!%<V\MO<1)+#*I1X
MW7*LI&""#U!% $@X&!0 4 % !0 4 1^3%Y_G>6OF[=N_'..N,^E $E !0 4
+% !0 4 % !0!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
